$INTT

Why is inTest stock climbing today?

inTest Corp (INTT) shares rose 1.7% in pre-open trading after Northland upgraded the stock to “outperform” from “market perform” and set a $15.00 price target. Northland cited inTest’s preliminary Q2 2026 revenue estimate of about $35M and raised full-year 2026 revenue guidance to $135M-$140M, while noting a planned 220 bps gross margin reduction.

Original reporting
Published Aug 3, 2026, 11:17 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 11:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$INTT
Bullish
medium confidence
Mentioned
$INTT
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$INTTBullishMed
01

Why it matters

For traders, the actionable elements are the same-day analyst upgrade with a stated $15 price target and the company’s raised FY revenue range, which can drive estimate revisions. The planned gross margin reduction is a material offset that may affect valuation multiples and near-term expectations.

02

Market read

Company-specific catalysts (upgrade plus raised revenue outlook) are the primary driver, with a supportive broader market backdrop amplifying the move.

03

What to watch

Preliminary results and guidance can change quickly; traders may fade the move if subsequent filings or margin commentary disappoint.

Relevance 7/10Novelty 7/10Timing: pre-open today

Background

The article attributes inTest’s pre-open climb to a Northland upgrade and a preliminary Q2 update released July 31, plus a raised full-year revenue outlook.

Company-level read

Ticker impact

$INTTBullishMedium confidence
Context

inTest shares rose pre-open after Northland upgraded the stock to outperform and set a $15 target, alongside raised FY revenue guidance.

Expected impact

Likely continued relative strength early as traders price the raised revenue outlook, but upside may be capped by the gross margin downgrade.

Evidence & confidence

The article cites a same-day analyst rating change with a specific price target and a preliminary Q2 revenue estimate plus raised FY outlook, which are direct catalysts for sentiment and estimates. The gross margin revision is a counterweight but is framed as not requiring amendments to filed reports.

Market effects

Positive read-through for semiconductor equipment and industrial testing sentiment, as the article links the move to sector optimism.

Primarily U.S. market sentiment tailwind via S&P 500, Dow, and Nasdaq gains.

Limited direct global linkage beyond general risk appetite and sector sentiment.

Counterpoint

The gross margin downgrade (220 bps) could signal cost pressure or demand mix issues, making the revenue raise less bullish than it appears.

Key entities

  • inTest Corporation

    Subject of the article, with shares up pre-open on an analyst upgrade and raised revenue outlook.

  • Northland

    Upgraded inTest from market perform to outperform and set a $15 price target.

Related articles

$INTTMedAI 8/10

InTest (INTT) Q2 2026 Earnings Call Transcript

InTest (INTT) reported Q2 2026 revenue of $35.3M, up 25.5% YoY, with semi orders $12.0M (+64% YoY) and backlog $45.4M (+19.8% YoY). Full-year guidance raised to $135M-$140M. Gross margin was 40.5% and adjusted EBITDA $2.2M. CFO cited a material weakness at Alfamation.

$INTTMed

INTEST CORP (INTT): Results of Operations and Financial Condition

INTEST CORP (INTT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE 804 EAST GATE DRIVE, SUITE 200, MOUNT LAUREL, NJ 08054 FOR IMMEDIATE RELEASE InTest Reports Strong Second Quarter 2026 Revenue of $35.3 Million EPS of $0.04 and Adjusted EPS (Non-GAAP) of $0.09 • Second quarter revenue up 25.5% year-over-year, driven lar

$INTTMed

INTEST CORP (INTT): Results of Operations and Financial Condition

INTEST CORP (INTT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE 804 EAST GATE DRIVE, SUITE 200, MOUNT LAUREL, NJ 08054 FOR IMMEDIATE RELEASE InTest Reports Preliminary Second Quarter 2026 Results • Second Quarter Revenue Estimated to be Approximately $35 Million • Second Quarter Gross Margin Estimated to be Approxima

$ROIVMedAI 8/10

What Lisraya’s $35,000 Monthly Price Could Mean for Roivant (ROIV)

Roivant Sciences (ROIV) and Priovant Therapeutics launched Lisraya, a $35,000/month dermatomyositis treatment, post-FDA approval. The drug's high price and small patient population present challenges, but its immediate launch and long exclusivity may drive adoption. ROIV owns 71% of Priovant, making Lisraya's success crucial for its financial outlook.

$BEMed

Bloom Energy (BE) Joins S&P 500: Can Its AI Rally Continue?

Bloom Energy (BE) will join the S&P 500 on September 21, effective before market open. The company's stock surged over 150% in 2026, driven by demand for its power solutions in AI data centers. Bloom Energy reported 166% revenue growth in Q2 and raised its full-year revenue outlook to $3.9B-$4.2B. The company has partnerships with Oracle and Brookfield Asset Management, aiming to accelerate fuel cell deployment.

$PCGMed

PG&E (PCG) and Edison (EIX) Sink After California Wildfire Liability Deal Falls Apart

PG&E (PCG) and Edison (EIX) shares fell after California lawmakers introduced a bill without liability protection for utilities. Analysts downgraded both stocks, and PG&E cut its 2027 capital investment plan by $2 billion. PG&E reaffirmed its FY 2026 earnings guidance and initiated FY 2027 guidance. Both companies face significant wildfire liability risks, with PG&E potentially covering 48% of the state's wildfire liability fund.